Boston University
Unraveling schizophrenia risk: contributions of high-risk genes and the impact of early life stress
Abstract
dc:description.abstractSchizophrenia is a devastating and undertreated disease, affecting approximately 1% of the general population. The causes of the disease are still an active area of research, with focus on environmental risk factors, such as early life stress, and genetic risk factors, like the immune gene C4 or the newly discovered high-risk SCHEMA genes from the recent study by the Broad Institute. While many risk factors have been identified, few have been explored in depth to determine the mechanism by which they lead to increased disease risk. We sought to explore the intersection of these two categories of risk factors and examine how environmental risk factors impact known high-risk genes. Using a previously established early life stress model using limited bedding and nesting, we found impairments in object recognition memory and an increase in oxidative stress in the anterior cingulate cortex. High-throughput multiplexed fluorescent in situ hybridization measured the expression of all ten SCHEMA genes and revealed region-specific expression patterns, with enrichment in brain regions with high levels of glutamatergic signaling, developmental changes in gene expression, and genes differentially expressed between males and females. Notably, the transcription factor Sp4 emerged as a stress-responsive gene upregulated immediately after ELS, positioning it as a potential master regulator connecting stress response to SCZ pathogenesis through its regulation of glutamatergic and GABAergic receptor expression. We also explored the impact of a genetic risk factor, complement component 4 (C4), mechanistically on brain functionality. Our lab previously showed that overexpression of C4 in pyramidal neurons of the medial prefrontal cortex (mPFC) leads to decreased spine density and impaired social behavior. In this study, we identified SNX27, an endosomal trafficking protein, as a C4 interaction partner, and we found C4 overexpression led to disrupted AMPA receptor trafficking in the late endosomes and endo-lysosomes. Using our novel Cre-dependent C4 mouse line, we also found that parvalbumin interneuron-specific C4 overexpression led to male-specific increases in anxiety-like behavior and decreased excitatory drive to parvalbumin neurons, while females showed increased parvalbumin cell excitability, suggesting compensatory mechanisms. These findings highlight cell-type specificity in C4’s effect as a risk gene and reveals the mechanisms underlying how C4 disrupts synaptic function. Overall, our research underscores the importance of examining both genetic vulnerabilities and environmental stressors in SCZ pathogenesis, demonstrating their convergence on synaptic dysregulation through multiple molecular pathways. The identification of Sp4 as a stress-responsive transcriptional regulator and the elucidation of C4’s non-canonical effects on synaptic function provide valuable insights into potential therapeutic targets for addressing the complex neurodevelopmental disruptions underlying SCZ.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Biology
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Brack, Alison
- Advisor dc:contributor.advisor
-
- Cruz-Martin, Alberto
- ORCID dc:identifier.orcid
Subjects
dc:subject × 3Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53274